SEC 13F Intelligence

Cx Institutional / ABBV

Cx Institutional’s Abbvie Inc Position

Does Cx Institutional own Abbvie Inc (ABBV)? Yes78.3K shares worth $20M (+0.57% of its 13F portfolio) as of Q2 2026, down from 90.0K shares the prior filed quarter.

Position Value
$20M
Q2 2026
Shares
78.3K
% of Portfolio
+0.57%
Quarters Held
30
currently held

Position History ABBV

Reported value by quarter
Q1 ’19: $753,000Q1 ’19Q2 ’19: $810,000Q3 ’19: $709,000Q4 ’19: $793,000Q1 ’20: $675,000Q1 ’20Q2 ’20: $1MQ3 ’20: $1MQ4 ’20: $1MQ1 ’21: $1MQ1 ’21Q2 ’21: $1MQ3 ’21: $1MQ4 ’21: $2MQ1 ’22: $2MQ1 ’22Q2 ’22: $2MQ3 ’22: $8MQ4 ’22: $6MQ1 ’23: $7MQ1 ’23Q2 ’23: $6MQ3 ’23: $8MQ4 ’23: $8MQ1 ’24: $11MQ1 ’24Q2 ’24: $10MQ3 ’24: $14MQ4 ’24: $12MQ1 ’25: $15MQ1 ’25Q2 ’25: $12MQ3 ’25: $20MQ4 ’25: $20MQ1 ’26: $20MQ1 ’26Q2 ’26: $20Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q2 202678.3K$20M+0.57%
Q1 202690.0K$20M+0.60%
Q4 202585.9K$20M+0.59%
Q3 202585.4K$20M+0.60%
Q2 202565.3K$12M+0.42%
Q1 202569.5K$15M+0.55%
Q4 202470.3K$12M+0.50%
Q3 202470.4K$14M+0.62%
Q2 202459.1K$10M+0.48%
Q1 202458.7K$11M+0.51%
Q4 202353.5K$8M+0.44%
Q3 202353.5K$8M+0.44%
Q2 202341.5K$6M+0.29%
Q1 202344.0K$7M+0.38%
Q4 202239.1K$6M+0.38%
Q3 202259.9K$8M+0.56%
Q2 202212.4K$2M+0.14%
Q1 202212.3K$2M+0.16%
Q4 202113.4K$2M+0.14%
Q3 202113.0K$1M+0.11%
Q2 202113.2K$1M+0.12%
Q1 202112.8K$1M+0.12%
Q4 202012.7K$1M+0.13%
Q3 202011.9K$1M+0.11%
Q2 202011.6K$1M+0.15%
Q1 20208.9K$675,000+0.11%
Q4 20199.0K$793,000+0.14%
Q3 20199.4K$709,000+0.11%
Q2 201911.1K$810,000+0.13%
Q1 20199.3K$753,000+0.13%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Cx Institutional’s full portfolio or all institutional holders of ABBV.